Employee Complaint Form Pay Online Download Product List Download Profile

Blog

  • Home
  • Blog
  • Mirabegron 25mg ER + Solifenacin 5mg Tablets for Overactive Bladder (OAB) Management

Mirabegron 25mg ER + Solifenacin 5mg Tablets for Overactive Bladder (OAB) Management

  • 29-06-2026

Mirabegron 25mg ER + Solifenacin 5mg Tablets for Overactive Bladder (OAB) Management

Overactive Bladder (OAB) is a common urological condition that affects millions of people worldwide. It is characterized by a sudden urge to urinate, increased urinary frequency, nighttime urination (nocturia), and urge urinary incontinence. These symptoms can interfere with daily activities, disturb sleep, and significantly reduce quality of life.

MIRDOT-S-25/5 Tablets combine Mirabegron 25mg Extended Release (ER) and Solifenacin 5mg, two clinically proven medications that work through different mechanisms to provide comprehensive management of Overactive Bladder (OAB). This dual-action therapy helps reduce urinary urgency, urinary frequency, and episodes of urge incontinence while improving bladder control.

What are Mirabegron 25mg ER + Solifenacin 5mg Tablets?

Mirabegron 25mg ER + Solifenacin 5mg Tablets are a combination medicine prescribed for adults with Overactive Bladder (OAB) who experience symptoms such as:

  • Sudden urinary urgency

  • Frequent urination

  • Urge urinary incontinence

  • Nighttime urination (Nocturia)

The combination therapy provides better symptom control than using a single medication alone in many patients.

Composition

Active Ingredients

Mirabegron 25mg Extended Release

Mirabegron is a beta-3 adrenergic receptor agonist that relaxes the bladder muscle during the storage phase, allowing the bladder to hold more urine and reducing frequent urges to urinate.

Solifenacin 5mg

Solifenacin is an antimuscarinic agent that reduces involuntary bladder muscle contractions responsible for urgency and urinary leakage.

Together, these two medicines offer comprehensive bladder symptom management.

Understanding Overactive Bladder (OAB)

Overactive Bladder is not a disease but a collection of urinary symptoms caused by abnormal bladder muscle activity.

Common symptoms include:

  • Sudden, difficult-to-control urge to urinate

  • Frequent urination throughout the day

  • Waking up multiple times at night to urinate

  • Leakage before reaching the toilet

  • Reduced bladder control

Early diagnosis and proper treatment can significantly improve everyday comfort and confidence.

How Mirabegron 25mg ER + Solifenacin 5mg Works

The combination works through two complementary mechanisms.

Mirabegron Helps Relax the Bladder

Mirabegron:

  • Increases bladder storage capacity

  • Reduces urgency episodes

  • Lowers urinary frequency

  • Improves bladder relaxation

Solifenacin Controls Bladder Muscle Activity

Solifenacin:

  • Reduces involuntary bladder contractions

  • Helps decrease urge incontinence

  • Improves urinary control

  • Supports better bladder function

Together, they provide comprehensive symptom relief for patients with OAB.

Benefits of MIRDOT-S-25/5 Tablets

Reduces Urinary Urgency

Helps minimize the sudden urge to urinate.

Controls Frequent Urination

Supports longer intervals between bathroom visits.

Improves Bladder Capacity

Allows the bladder to comfortably store more urine.

Reduces Urge Urinary Incontinence

Helps decrease accidental urine leakage associated with OAB.

Improves Nighttime Bladder Control

May help reduce frequent nighttime urination.

Enhances Quality of Life

Better bladder control allows patients to perform daily activities with greater confidence.

Indications

MIRDOT-S-25/5 Tablets are indicated for:

  • Overactive Bladder (OAB)

  • Urinary urgency

  • Increased urinary frequency

  • Urge urinary incontinence

  • Bladder overactivity management

Treatment should always be taken under the supervision of a qualified healthcare professional.

Who Can Benefit from MIRDOT-S-25/5?

This medication may be prescribed for adults who experience:

  • Frequent urination

  • Sudden urinary urgency

  • Urge incontinence

  • Poor bladder control

  • Symptoms of Overactive Bladder

A healthcare provider will determine whether this combination therapy is appropriate based on individual medical needs.

Dosage and Administration

  • Take MIRDOT-S-25/5 Tablets exactly as prescribed by your doctor.

  • Swallow the tablet whole with water.

  • Do not crush or chew the extended-release tablet.

  • Take the medicine at the same time each day for consistent symptom control.

  • Continue treatment as advised, even if symptoms begin to improve.

Safety and Precautions

Before using MIRDOT-S-25/5 Tablets:

  • Inform your doctor about kidney or liver disease.

  • Discuss all current medications to avoid interactions.

  • Use only under medical supervision.

  • Do not alter the prescribed dose without consulting your healthcare provider.

Regular follow-up may be recommended to monitor treatment effectiveness.

Why Choose MIRDOT-S-25/5 Tablets?

Dual-Action Therapy

Combines Mirabegron ER and Solifenacin for comprehensive bladder symptom management.

Clinically Established Ingredients

Contains two widely prescribed medicines for Overactive Bladder treatment.

Improves Bladder Function

Supports better urine storage and reduces involuntary bladder contractions.

Convenient Once-Daily Treatment

Extended-release formulation provides sustained symptom control.

Quality-Assured Formulation

Manufactured according to stringent pharmaceutical quality standards for consistent performance.

Frequently Asked Questions 

1. What are Mirabegron 25mg ER + Solifenacin 5mg Tablets used for?

They are used to treat Overactive Bladder (OAB), urinary urgency, frequent urination, and urge urinary incontinence.

2. How does Mirabegron work?

Mirabegron relaxes the bladder muscle, allowing it to hold more urine and reducing urgency.

3. What does Solifenacin do?

Solifenacin reduces involuntary bladder muscle contractions that cause urgency and urine leakage.

4. Can this combination improve bladder control?

Yes. The combination helps improve bladder capacity, reduce urgency, and decrease urinary frequency and incontinence episodes.

5. Is MIRDOT-S-25/5 suitable for long-term management?

Your healthcare provider will determine the appropriate duration of treatment based on your medical condition and response.

Conclusion

MIRDOT-S-25/5 Tablets combine Mirabegron 25mg Extended Release and Solifenacin 5mg to provide an effective dual-action treatment for Overactive Bladder (OAB). By improving bladder storage capacity, reducing involuntary contractions, and minimizing urinary urgency and frequency, this combination therapy helps patients regain confidence and improve their quality of life.

When taken as prescribed by a healthcare professional, MIRDOT-S-25/5 offers a reliable solution for long-term management of Overactive Bladder symptoms and better urinary health.

Share With: